Opendata, web and dolomites

SHN SIGNED

Universal Smart Hypodermic Needle for preventing reuse and accidental pricks

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "SHN" data sheet

The following table provides information about the project.

Coordinator
VASTAGO INTERNATIONAL SL 

Organization address
address: C/GENERAL ASENSIO CABANILLAS 5 8 A
city: MADRID
postcode: 28003
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.ahiuniversal.com/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VASTAGO INTERNATIONAL SL ES (MADRID) coordinator 50˙000.00

Map

 Project objective

VASTAGO INTERNATIONAL Ltd emerged with the aim of developing a new technology that solves the problems associated with reuse or share syringes and accidental needlestick injuries causing millions of deaths since the spread of infectious diseases. The creation of Smart Hypodermic Needle (SHN) solves these problems in a safe, cost effective way and adaptable to the most syringes of the marker according to the international LUER system. This device provides a high added value in biosecurity since its innovative biopolymer membrane and the self-retracting mechanism makes it automatic and retractable needle which is activated after its use independently of operator´s will. The overall objective of the SHN project is the industrial adaptation and the process scale-up for manufacturing the safety needle to implement it at the clinical level. Currently, the SHN prototype has a technology level TRL6 and it has been validated through trials simulating medical treatments procedures demonstrating their efficiency and viability. However, the company needs to work in the implementation of the business model, in the industrial adaptation of our prototype and, in achieving the certification of our system to be commercialized. The initial plan to commercialize the SHN consists in the combination of own production with a partner plus licensing of the technology. According to our estimation, the cumulative cash flow projected by VASTAGO INTERNATIONAL at year 5 will amount €52.6 M meaning a ROI of 219%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SHN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SHN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More